Introduction
The global burden of death and disability due to injuries is increasing, especially in patients younger than 40 years old [
1]. In the course of supportive management, injured patients often develop sepsis, which is the most frequent cause of complications and death following severe injury [
2]. Immunosuppression has emerged recently as a risk factor for sepsis in trauma patients [
3,
4]. It is now well established that any situation of injury or stress can induce a systemic inflammatory response that is often followed by an anti-inflammatory response [
5‐
7]. This compensatory feedback mechanism, which maintains inflammatory immune homeostasis, is believed to lower natural defenses against pathogens and contribute to a state of immunosuppression [
8‐
10] and is known to occur in cases of sepsis, septic shock, burns, stroke, and injury and in patients undergoing major surgery. Such alterations might be directly responsible for a detrimental outcome in trauma patients and for lowering the resistance to nosocomial infections in patients who have survived initial resuscitation [
7‐
9,
11].
In the absence of specific clinical signs of immune function in intensive care patients, biomarkers of immunosuppression are clearly highly desirable. Diminished expression of human leukocyte antigen DR expression on circulating monocytes (mHLA-DR) is widely accepted as a reliable indicator of immunosuppression in critically ill patients [
12‐
14]. Some work has been devoted to trauma patients, but for the most part, these preliminary studies were performed 10 years ago (that is, before the advent of the last advanced trauma life support [ATLS] protocol for the management of multiple-injury patients). Early findings on mHLA-DR were based on limited numbers of patients and used non-standardized flow cytometry protocols [
15‐
20]. The purpose of this study was to investigate mHLA-DR expression on the basis of the standardized protocol and to assess this expression as a predictive factor of infection in a multivariate analysis.
In the study described here, mHLA-DR expression was measured according to recently established flow cytometry protocols in a group of severely injured patients. The main objective of the study was to assess whether a low mHLA-DR expression might be a good predictor of infection in such patients.
Discussion
Severe injury is characterized by a systemic inflammatory response syndrome involving activation of several cellular systems and the overwhelming production, by the innate immune system, of proinflammatory cytokines and other inflammatory mediators. It is subsequently followed by a compensatory anti-inflammatory response syndrome [
35,
36]. This negative feedback mechanism has a protective effect over the first few hours after trauma but may become harmful if it persists. Considerable clinical and experimental evidence indicates that in such patients a number of immune functions are rapidly altered. Monocyte alterations, for example, can decrease phagocytosis, inflammatory cytokine expression, and antigen presentation because of the loss of mHLA-DR expression. Lymphocyte anergy and apoptosis can ensue [
3,
37‐
39]. These changes together may increase susceptibility to infection, which in turn could provoke multiple organ failure and death.
Diminished mHLA-DR expression has been proposed as a reliable biomarker of immunosuppression in ICU patients. Today, it is the most reliable marker and is used in most of the studies about ICU-acquired immunosuppression. More specifically, it has been shown to be a predictor of septic complications in several conditions, including surgical interventions, sepsis, burns, stroke, and pancreatitis [
11,
40‐
48]. Immunosuppression has long been postulated as a concomitant of trauma [
37,
49,
50]. In regard to mHLA-DR, the pioneering work of Polk and colleagues [
50] reported in 1986 revealed an association between the development of sepsis and low mHLA-DR expression. Subsequently, mHLA-DR expression was assessed as a predictor of sepsis in several series of severely injured patients [
15,
17,
18,
20,
39,
51‐
53]. A major limitation of these studies is that they were conducted over a 20-year period, during which time case management and methodologies for measurement of mHLA-DR expression have evolved, thereby complicating interpretation and comparison of the findings of these studies.
In the present cohort, incidence of sepsis was 35% and the mortality rate for the entire study was 6%. Though apparently high, these values are in concordance with those of a previous epidemiologic study by Osborn and colleagues [
2], in which incidence rates of sepsis were 42% for moderate injury (defined as an ISS of between 15 and 29) and 39% for severe injury (ISS of up to 30). Another epidemiologic study in trauma patients reported a low sepsis incidence, but most of the patients presented with mild injury (ISS of less than 15: 67.7%) and no brain injury [
54], the latter of which is known to be a risk factor for developing pneumonia [
55‐
58]. In our cohort, septic patients presented more trauma brain injury than the non-septic patients did, and this is in concordance with the literature.
The present study showed an overall reduction in mHLA-DR expression in trauma patients. Most importantly, in injured patients with an uneventful outcome, mHLA-DR expression returned to normal within a week. In contrast, in patients who developed infection, mHLA-DR levels remained low or fell even lower.
It would appear that the steepness of the slope of mHLA-DR recovery is a more significant indicator than the levels attained at a given point in time. Indeed, the incidence of sepsis was significantly greater in the group with a slope of less than 1.2 (days 3 and 4/days 1 and 2). This suggests that patients in whom recovery in mHLA-DR expression did not begin between days 1 and 2 and days 3 and 4 had an increased risk of developing sepsis. This observation is consistent with recent findings reported by Lukaszewicz and colleagues [
59] in surgical patients. Significantly, in the present study, multivariate logistic regression analysis indicated that low mHLA-DR expression was independently associated with the development of sepsis, whereas all the other parameters included in the analysis (ISS, SAPS II, presence of a severe brain trauma, and massive transfusion) were not predictive. A slope of mHLA-DR of less than 1.2 was independently associated with the risk of developing sepsis, a finding that reflects the possible pivotal role of immune dysfunction in the increased risk of infection in trauma patients. In Table
1 some variables that may seem relevant (like the length of stay in the ICU and the duration of mechanical ventilation) were not included in the multivariate analysis, because they have to be considered as a consequence of the development of sepsis and not a risk factor. Moreover, it has to be considered that the onset of sepsis is early (median at day 4) and that every patient was still in the ICU at this time point.
Chest trauma is reported to account for one third of acute-trauma emergency room admissions, and 30% to 75% of trauma patients have pulmonary contusions [
60], usually as a result of rapid deceleration [
61]. The incidence of lung injury seemed to be quite significant in our study (72%) and is probably due to the severity of the trauma patients included. However, there were no differences between the presences of thoracic injury between infected and non-infected groups. The pathophysiology of pulmonary contusion includes a strong inflammatory response in the lung parenchyma, resulting in increased alveolocapillary permeability, pulmonary edema, ventilation/perfusion mismatch, increased pulmonary shunting, and loss of compliance. As at the systemic level, this local response is followed by an anti-inflammatory response. Muehlstedt and colleagues [
19] observed not only altered HLA-DR expression on the surface of alveolar macrophages in the lungs of trauma patients who developed sepsis but also altered production of other cytokines. Local organ immunosuppression was present and may have been responsible for the development of nosocomial pneumonia in the injured patients [
19].
As far as the authors can ascertain, this is the first study, using the standardized test described by the European multicenter study [
33] and multivariate analysis, aimed specifically at evaluating mHLA-DR expression in a cohort of severe trauma patients. Most previous studies have been conducted in smaller series of patients spanning a highly variable spectrum of severity (from mild to severe trauma) [
15‐
17,
58]. Furthermore, these studies did not include multivariate analysis for assessment of the usual clinical confounders of mHLA-DR expression levels, nor did they exclude mHLA-DR expression data following onset of sepsis, as the present study did (see Materials and methods) in order to avoid bias from possible amplification by the sepsis itself of lowered mHLA-DR expression. Finally, the data from previous studies are not readily comparable, owing to differences, from one study to another, in the values studied (mainly 'percentages of positive monocytes' or 'mean fluorescence intensity'), which are generally specific for a given laboratory and therefore defy comparability on a wider scale. The European protocol now recommends expression of the results as numbers of antibodies per cell, a recommendation that will facilitate comparison of data obtained by different laboratories.
The present study has a number of limitations. First, it is a single-center study. The findings clearly need to be confirmed by a multicenter study. Second, the study enrolled only 105 patients. Though relatively small, the series was very homogeneous in terms of severity and also highly representative of the trauma patient population commonly encountered. Finally, mHLA-DR expression was measured every 2 days after trauma. However, the mean onset of infection was on day 4; in some patients, this limited the amount of analyzable mHLA-DR expression data available before day 4. In subsequent studies, follow-up of patients should consist of daily monitoring during the early post-trauma period. Indeed, one potentially interesting objective of a future study would be an assessment of the usefulness of daily mHLA-DR measurements to detect patients at an increased risk of infection. To pre-empt development of infection, clinicians could give these patients prophylactic treatment, such as antibiotics [
48], immunostimulant by interferon-gamma [
62], or granulocyte-macrophage colony-stimulating factor, as used in septic shock [
35].
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
AC helped to design the study, collected the clinical information, analyzed the raw data, performed statistical analysis, drafted the paper, and contributed to the writing of the paper. BF helped to design the study and to include patients, participated with AC in the interpretation of all data, and contributed to the writing of the paper. BA and GMo helped to design the study, participated with AC in the interpretation of all data, and contributed to the writing of the paper. CaG, FP, and CM helped to perform the experiments. JC, AF, ChG, GMa, AV, and OM helped to include patients. All authors read and approved the final manuscript.